Long-term follow-up (median 7.0 years) of 107 of 179 eligible patients with chronic central serous chorioretinopathy from two trials: those with a successful first half-dose PDT had better BCVA and less subretinal fluid (16.7% vs 44.8%) than those with an unsuccessful one.
RCTn = 107
van den Tillaart et al. Long-Term Follow-Up of PLACE and SPECTRA Trials: Outcomes After Successful and Unsuccessful Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy